Floatz logo

PTEROYLMONOGLUTAMIC ACID HYDROLASE G2

Central Nervous System Lymphoma

Assistance Publique - Hôpitaux de Parisprotein_peptidePhase 1Active
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
35/ 100
Competitive Position
81/ 100

Competitive context

73 Active assets in the Central Nervous System Lymphoma cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 4BBB
(+)-VINCRISTINE
Ono Pharmaceutical Co., Ltd.
Phase 4BBB
METHOTREXATE
Assistance Publique Hopitaux De Marseille
Phase 4BB
Inno-206
Juan P. Alderuccio, MD
Phase 4BB
Idarubicine
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 4BB

View all 50 →

Same molecule, other indications

PTEROYLMONOGLUTAMIC ACID HYDROLASE G2 is also rated in:

acute lymphoblastic leukemiaDormant
BB
Indicative ·
64 / 100
View asset →
lymphomaDormant
B
Indicative ·
59 / 100
View asset →
toxic encephalopathyDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →